OliX Pharmaceuticals (XKRX:226950) Short-Term Debt : ₩7,446 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is OliX Pharmaceuticals Short-Term Debt?

OliX Pharmaceuticals's Short-Term Debt for the quarter that ended in Mar. 2025 was ₩7,446 Mil.

OliX Pharmaceuticals's quarterly Short-Term Debt declined from Sep. 2024 (₩18,988 Mil) to Dec. 2024 (₩17,013 Mil) and declined from Dec. 2024 (₩17,013 Mil) to Mar. 2025 (₩7,446 Mil).

OliX Pharmaceuticals's annual Short-Term Debt declined from Dec. 2022 (₩19,230 Mil) to Dec. 2023 (₩0 Mil) but then increased from Dec. 2023 (₩0 Mil) to Dec. 2024 (₩17,013 Mil).

OliX Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for OliX Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OliX Pharmaceuticals Short-Term Debt Chart

OliX Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

16,405.32

19,230.31

17,012.78

OliX Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Debt	Get a 7-Day Free Trial															714.44	18,273.81	18,988.09	17,012.78	7,446.06

OliX Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

OliX Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of OliX Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

OliX Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OliX Pharmaceuticals Inc (XKRX:226950) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1014 Gwanggyo Ace Tower 1, Daehak 4-ro, Yeongtong-gu, Gyeonggi, Suwon, KOR, 16226

Website

http://www.olixpharma.com

OliX Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in developing RNA interference (RNAi) technology therapeutics for dermal, ophthalmic and pulmonary diseases. The company's pipeline products include OLX101, OLX201, OLX301, OLX102, and others.

OliX Pharmaceuticals Headlines

No Headlines